The tweet was deleted by the author.
But we saved everything 🙂.
Emergent Biosolutions has entered a partnership with British Columbia to provide NARCAN nasal spray as part of the expansion of the province's Take Home Naloxone Program.
The agreement aims to enhance access to life-saving opioid overdose reversal medication throughout the region. The NARCAN nasal spray will be distributed to support British Columbia's efforts to combat the ongoing public health crisis related to opioid overdoses. Further details about the partnership can be found on Emergent Biosolutions' official website.
Emergent Biosolutions recently launched cases for NARCAN Nasal Spray to encourage wider access to overdose response tools, according to a past company statement here. The company also committed 2026 Cycle A funding to charitable organizations focused on health, scientific education, and veteran support here. These initiatives reflect Emergent's ongoing involvement in public health efforts.